Lynn Seely brings ex-Myovant colleague to Lyell's C-suite; Nkarta, Zai Lab name new CFOs
→ Lyell Immunopharma, the cell therapy shop co-founded and chaired by Rick Klausner that made the Endpoints 11 in 2020, has tapped Matthew Lang as CBO, chief legal officer and corporate secretary. Lang and first-year Lyell CEO Lynn Seely know each other well from their days at Myovant, when Seely was chief executive and Lang filled such roles as chief administrative and legal officer, and managing director/general manager of European operations. To close out nearly eight years with Gilead, Lang was VP, head of global litigation, investigations, employment law and information governance.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.